MicroTech Medical (02235) Announces H-Share Repurchase and Adjusted Treasury Shares

Bulletin Express

Feb 16

MicroTech Medical (Hangzhou) Co., Ltd. (stock code: 02235) announced a repurchase of 10,800 H shares on 16 February 2026 through the Hong Kong Stock Exchange, with the highest repurchase price at HKD 7.35 and the lowest at HKD 7.26 per share, totaling HKD 78,930.

The company’s opening balance on 9 February 2026 showed 165.74 million shares in issue and 3.43 million treasury shares, out of a total of 169.18 million shares. After the repurchase, issued shares (excluding treasury shares) stood at 165.73 million, while treasury shares rose to 3.44 million. The total share capital remained 169.18 million shares.

This repurchase was conducted under a mandate approved on 28 May 2025, which authorized repurchases of up to 16.67 million shares. Since the mandate was granted, the company has repurchased a total of 891,400 shares, representing 0.53% of the issued share base on the approval date. The new-share issuance moratorium now extends to 16 March 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1144426596"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1144426596\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1144426596?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-02-16 13:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1144426596","market":"us","top_or_hot":-1,"title":"MicroTech Medical (02235) Announces H-Share Repurchase and Adjusted Treasury Shares","media":"Bulletin Express","content":"<p>MicroTech Medical (Hangzhou) Co., Ltd. (stock code: 02235) announced a repurchase of 10,800 H shares on 16 February 2026 through the Hong Kong Stock Exchange, with the highest repurchase price at HKD 7.35 and the lowest at HKD 7.26 per share, totaling HKD 78,930.</p>\n<p>The company’s opening balance on 9 February 2026 showed 165.74 million shares in issue and 3.43 million treasury shares, out of a total of 169.18 million shares. After the repurchase, issued shares (excluding treasury shares) stood at 165.73 million, while treasury shares rose to 3.44 million. The total share capital remained 169.18 million shares.</p>\n<p>This repurchase was conducted under a mandate approved on 28 May 2025, which authorized repurchases of up to 16.67 million shares. Since the mandate was granted, the company has repurchased a total of 891,400 shares, representing 0.53% of the issued share base on the approval date. The new-share issuance moratorium now extends to 16 March 2026.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>MicroTech Medical (02235) Announces H-Share Repurchase and Adjusted Treasury Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMicroTech Medical (02235) Announces H-Share Repurchase and Adjusted Treasury Shares\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-02-16 13:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>MicroTech Medical (Hangzhou) Co., Ltd. (stock code: 02235) announced a repurchase of 10,800 H shares on 16 February 2026 through the Hong Kong Stock Exchange, with the highest repurchase price at HKD 7.35 and the lowest at HKD 7.26 per share, totaling HKD 78,930.</p>\n<p>The company’s opening balance on 9 February 2026 showed 165.74 million shares in issue and 3.43 million treasury shares, out of a total of 169.18 million shares. After the repurchase, issued shares (excluding treasury shares) stood at 165.73 million, while treasury shares rose to 3.44 million. The total share capital remained 169.18 million shares.</p>\n<p>This repurchase was conducted under a mandate approved on 28 May 2025, which authorized repurchases of up to 16.67 million shares. Since the mandate was granted, the company has repurchased a total of 891,400 shares, representing 0.53% of the issued share base on the approval date. The new-share issuance moratorium now extends to 16 March 2026.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02235","symbol_name":"微泰医疗-B","start_time":0,"source_url":"","article_id":"1144426596","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1144426596","pubTimestamp":1771220599,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"MicroTech Medical (Hangzhou) Co., Ltd. (stock code: 02235) announced a repurchase of 10,800 H shares on 16 February 2026 through the Hong Kong Stock Exchange, with the highest repurchase price at HKD...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02235":"微泰医疗-B"},"translate_title":"微科医疗(02235)公布H股回购及经调整库存股","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02235":1},"content_text":"MicroTech Medical (Hangzhou) Co., Ltd. (stock code: 02235) announced a repurchase of 10,800 H shares on 16 February 2026 through the Hong Kong Stock Exchange, with the highest repurchase price at HKD 7.35 and the lowest at HKD 7.26 per share, totaling HKD 78,930.\nThe company’s opening balance on 9 February 2026 showed 165.74 million shares in issue and 3.43 million treasury shares, out of a total of 169.18 million shares. After the repurchase, issued shares (excluding treasury shares) stood at 165.73 million, while treasury shares rose to 3.44 million. The total share capital remained 169.18 million shares.\nThis repurchase was conducted under a mandate approved on 28 May 2025, which authorized repurchases of up to 16.67 million shares. Since the mandate was granted, the company has repurchased a total of 891,400 shares, representing 0.53% of the issued share base on the approval date. The new-share issuance moratorium now extends to 16 March 2026.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}